On 6 June 2017, the World Health Organization (WHO) published updates to its ‘Essential Medicines List’ (EML). Read more here.

Eurosurveillance is on the updated list of the Directory of Open Access Journals and in the SHERPA/RoMEO database. Read more here.

Follow Eurosurveillance on Twitter: @Eurosurveillanc

In this issue

Home Eurosurveillance Edition  2012: Volume 17/ Issue 4 Article 2
Back to Table of Contents
Previous Download (pdf)

Eurosurveillance, Volume 17, Issue 4, 26 January 2012
Rapid communications
Outbreak of haemolytic uraemic syndrome due to Shiga toxin-producing Escherichia coli O104:H4 among French tourists returning from Turkey, September 2011
  1. French Institute for Public Health Surveillance (Institut de veille sanitaire), St Maurice, France
  2. Regional Office of the French Institute for Public Health Surveillance, Caen, France
  3. Institut Pasteur, National Reference Centre for Escherichia coli and Shigella, Paris, France
  4. University Hospital of Caen, Neurology department, Caen, France
  5. University Hospital of Caen, Nephrology department, Caen, France
  6. Laboratory associated to the National Reference Centre for Escherichia coli and Shigella, Robert Debré Hospital, Paris, France

Citation style for this article: Jourdan-da Silva N, Watrin M, Weill FX, King LA, Gouali M, Mailles A, van Cauteren D, Bataille M, Guettier S, Castrale C, Henry P, Mariani P, Vaillant V, de Valk H. Outbreak of haemolytic uraemic syndrome due to Shiga toxin-producing Escherichia coli O104:H4 among French tourists returning from Turkey, September 2011. Euro Surveill. 2012;17(4):pii=20065. Available online:
Date of submission: 06 January 2012

Eight cases of diarrhoea, including two cases of haemolytic uraemic syndrome (HUS), were identified among 22 French tourists who travelled to Turkey in September 2011. A strain of Escherichia coli O104:H4 stx2-positive, eae-negative, hlyA-negative, aggR-positive, ESBL-negative was isolated from one HUS case. Molecular analyses show this strain to be genetically similar but not indistinguishable from the E. coli O104:H4 2011 outbreak strain of France and Germany. Although the source of infection was not identified, we conclude that the HUS cases had probably been infected in Turkey.

On 30 September 2011, the University Hospital of Caen in western France informed the local health authorities of two cases of post-diarrhoeal haemolytic uraemic syndrome (HUS) in adults returning from an organised bus tour in Turkey that had taken place between 4 and 17 September 2011. Both cases were women in their 60s. They had not known each other prior to their journey to Turkey. Diarrhoea onset was 15 September for both cases. They were hospitalised following their return from Turkey and HUS was diagnosed on 20 and 26 September 2011. Initial information obtained from the concerned travel agency indicated the occurrence of additional cases of diarrhoea among other members of this travel group during the trip to Turkey.

Epidemiological investigation

A case was defined as a person with diarrhoea, bloody diarrhoea or HUS, with a date of symptom onset between 4 September and 2 October 2011, who was a member of the group having travelled to Turkey between 4 and 17 September 2011. A case of HUS was defined as acute renal failure and either microangiopathic haemolytic anaemia and/or thrombocytopenia.

The tour operator was contacted to identify any additional cases among individuals of groups who subsequently travelled on the same bus tour.

All 22 travellers of the group were interviewed using a standardised semi-structured questionnaire exploring symptoms, food consumption including sprouts, activities undertaken during the trip to Turkey, and contact with animals or other cases of diarrhoea in the seven days before symptom onset. 

Case description

As of 4 October 2011, six additional cases were identified, bringing the total number of cases to eight. Among the eight cases, six were women and two were men with a median age of 64 years (range: 51-71 years). Five cases presented with diarrhoea, one case initially with diarrhoea and a second episode of bloody diarrhoea four days later, and two cases with bloody diarrhoea evolving into HUS. Cases had symptom onset between 6 and 15 September with an initial group of five cases occurring on 6 and 7 September and three cases occurring later during the trip (Figure 1). One case consulted a hospital emergency room for bloody diarrhoea during the trip and was not admitted. Both HUS cases were hospitalised following their return to France. One HUS case was discharged after five days of hospitalisation while the second case, who had a transient ischemic attack, was discharged after nine days of hospitalisation.

Figure 1. Cases of haemolytic uraemic syndrome due to Shiga toxin-producing Escherichia coli O104:H4, diarrhoea or bloody diarrhoea, by date of symptom onset, among French tourists returning from Turkey, September 2011 (n=8)

The group’s two-week bus itinerary in Turkey took them from Istanbul to Ankara, Cappadocia, Aksaray, Konya, Pamukkale, Aphrodesia, Kudsadai, Priene, Miletus, Didymus, Izimir, Selçuk, Pergamum and Bursa. Due to the relatively long stay in Turkey, and the fact that the group stayed in nine different hotels and repeatedly ate similar foods in numerous restaurants, often with buffet style meals, we were unable to identify a specific food that might have been associated with illness. While group members could usually remember having eaten a certain food item, they could not remember on what date, how often or during which specific meals they had consumed this item. No member of the group reported having eaten sprouts during the trip to Turkey or before departure to Turkey.

Following the initial interview, a second questionnaire focusing specifically on food items eaten at the airport before boarding the plane, during the flight from Paris to Istanbul on 4 September and during the first two days of the tour was undertaken. The objectives were to exclude the hypothesis of contamination before arrival in Turkey and to identify a food consumed during the first 48 hours after arrival in Turkey that could have explained the five initial cases. Information on the menus served during the flight from Paris to Istanbul was obtained from the airline’s catering company. Group members reported no common meal or food shared before boarding the plane in Paris and none brought food to the airport to share among the group. Two menus were available during the flight with a choice of poultry or smoked fish as a main course. Neither menu was common to all cases. The group members had difficulty remembering specific foods items served during the 48 hours after arrival in Turkey. These data were not sufficiently robust for further analysis.

Microbiological and serological investigation

Shiga toxin-producing Escherichia coli (STEC) O104:H4 possessing the gene stx2 but not the genes coding for intimin (eae) and haemolysin (hlyA) was isolated from one of the HUS patients. The strain was also negative for the gene coding EAST1 toxin (astA) and positive for the aggA gene which encodes the aggregative adherence fimbriae type I (AAF/I). Analyses on the stool of the second HUS patient were negative for STEC O104:H4. The STEC O104:H4 isolate had the following antibiotic resistance profile: ampicillin-resistant (R), streptomycin R, sulphonamide R, trimethoprim R, cotrimoxazole R, tetracycline R, nalidixic acid R, cefotaxime-sensitive (S), ceftazidime S, imipenem S, kanamycin S, gentamicin S, chloramphenicol S, and ciprofloxacin S. Except the absence of an extended-spectrum beta-lactamase, the resistance profile of this isolate was similar to the profile of the strain involved in the recent STEC O104:H4 outbreaks in Germany and Bordeaux in France linked to the consumption of sprouts in May-June 2011 [1,2].

The strain isolated from the HUS case returning from Turkey was compared by pulsed-field gel electrophoresis (PFGE) using XbaI and NotI [3] to STEC O104:H4 stx2 strains isolated from two imported cases in France linked to the German 2011 outbreak, ten patients in the Bordeaux outbreak in 2011, and two sporadic cases isolated in France in 2004 and 2009 (Figures 2 and 3). Previous molecular analyses had shown the genetic relatedness of the Bordeaux and German O104:H4 strains [1]. The XbaI- and NotI-PFGE profiles of the strain isolated from the HUS case returning from Turkey were close but not identical (differences in two bands for XbaI and in three bands for NotI) to those of the German and Bordeaux O104:H4 2011 outbreak strains. PFGE also showed that the strain isolated from the patient returning from Turkey was unrelated to the two O104:H4 stx2 aggR agg3A strains isolated previously in France in 2004 and 2009 [4].

In addition, both HUS cases had a positive serology for E. coli O104. Serological testing was performed by a line blot immunoassay using lipopolysaccharides of seven major serogroups of STEC (O26, O91, O103, O111, O128, O145, O157) and of O104 (extracted from a clinical O104:H4 isolate) [5].

Figure 2. PFGE profiles (XbaI) obtained from one STEC O104:H4 isolate from a French traveller returning from Turkey and other STEC O104:H4 outbreak isolates from France and Germanya and from various Escherichia coli O104 reference strains

Figure 3. PFGE profiles (NotI) obtained from the STEC O104:H4 isolates linked to the outbreak cases, France 2011

Biological samples were not systematically taken from non-HUS cases as they were no longer symptomatic at the time of the investigation. At the initiative of the treating physician, a stool sample was taken from one case and a serum sample from another, both 28 days after the start of diarrhoea. Both analyses were negative.

Control measures

Colleagues in other European countries were informed of this outbreak on 4 October via the Epidemic Intelligence Information System (EPIS) of the European Centre of Disease Prevention and Control (ECDC) and Early Warning Response System (EWRS) with the request to report any similar cases.

Germany reported the occurrence of two adult cases of infection with ESBL-negative STEC O104:H4 stx2 among persons returning from Turkey in July and August 2011. They had developed bloody diarrhoea 11 days and 18 after days after returning from Turkey, where both had stayed in Istanbul and one had additionally spent time at the Black Sea (personal communication, Dirk Werber, January 2012).

Moreover, Danish colleagues reported an STEC O104:H4 stx2 infection in an adult with diarrhoea onset on 28 September, two days before the end of a month’s stay in private homes in Ankara (personal communication, Charlotte Kjelsø, January 2012).

Contact with the travel agency showed that none of the tourists having subsequently travelled on the same bus tour reported developing diarrhoea. As evidence suggested that this outbreak was limited to tourists from this single travel group, no particular control measures were put in place.


There is no evidence to link this STEC O104:H4 outbreak to the consumption of fenugreek sprouts, as was the case for the German and French outbreaks in May to June 2011 [6-9]. None of the 22 travel group members reported the consumption of sprouts before and during their trip to Turkey.

Microbiological or serological evidence of STEC O104:H4 infection was only obtained for the two HUS cases. Considering that the median incubation period described for STEC O104:H4 is eight to nine days (range: two to 18 days) [10] and that these cases developed their symptoms 11 days after their arrival in Turkey, it is probable that they were infected during their stay in Turkey. In addition, these cases did not know each other before their trip to Turkey, they do not live in the same town and they consumed no common foods before or during their flight to Turkey, which provides further evidence in favour of this hypothesis. No source of contamination could be identified for these cases.
The fact that the six initial diarrhoea cases did not share a common food before or during the flight to Turkey suggests that they were infected following their arrival in Istanbul. However, their reported incubation period was much shorter than that of the HUS cases. Moreover, none were confirmed as STEC O104:H4 infection. Thus, this cluster may have been due to another pathogen and may have been a distinct event not linked to the HUS cases.

Turkey is among several destinations where European tourists had previously travelled before developing STEC O104 infection between 2004 and 2009 (n=4), along with Afghanistan, Egypt and Tunisia [11]. This outbreak supports data suggesting that the STEC serogroup O104 circulates in these areas. Further evidence is provided by the three additional cases that were subsequently identified in Germany and Denmark among persons also returning from Turkey within the same approximate time frame. Public health authorities and clinicians should be vigilant for possible STEC O104 infection in individuals returning from these areas who present with post-diarrhoeal HUS.


The authors wish to  acknowledge the Agence Régionale de Santé de Basse-Normandie, the Tour operator, the French tourists,  Gilles Delmas, Elisabeth Couturier,  Véronique Goulet, Harold Noël, Christine Campese, Dounia Bitar and Francesco Nogareda at the Institut de Veille Sanitaire for their assistance in the investigation of this outbreak. 

We additionally acknowledge Dirk Werber of the Robert Koch Institute in Berlin and Charlotte Kjelsø of the Statens Serum Institut in Copenhagen for sharing information on the cited German and Danish cases of STEC O104:H4 infection.


  1. Mariani-Kurkdjian P, Bingen E, Gault G, Jourdan-Da Silva N, Weill FX. Escherichia coli O104:H4 south-west France, June 2011. Lancet Infect Dis. 2011;11(10):732-3.
  2. Bielaszewska M, Mellmann A, Zhang W, Köck R, Fruth A, Bauwens A, et al. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. Lancet Infect Dis. 2011;11(9):671-6.
  3. Ribot EM, Fair MA, Gautom R, Cameron DN, Hunter SB, Swaminathan B, et al. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis. 2006;3(1):59-7.
  4. Monecke S, Mariani-Kurkdjian P, Bingen E, Weill FX, Balière C, Slickers P, et al. Presence of enterohemorrhagic Escherichia coli ST678/O104:H4 in France prior to 2011. Appl Environ Microbiol. 2011;77(24):8784-6.
  5. Raoult D, Dasch G. The line blot: an immunoassay for monoclonal and other antibodies. J Immunol Methods. 1989;125(1-2):57–65.
  6. Frank C, Werber D, Cramer JP, Askar M, Faber M, an der Heiden M, et al. Epidemic Profile of Shiga-Toxin–Producing Escherichia coli O104:H4 Outbreak in Germany. N Engl J Med. 2011;365(19):1771-80.
  7. Gault G, Weill FX, Mariani-Kurkdjian P, Jourdan-da Silva N, King L, Aldabe B, et al. Outbreak of haemolytic uraemic syndrome and bloody diarrhoea due to Escherichia coli O104:H4, south-west France, June 2011. Euro Surveill. 2011;16(26):pii=19905. Available from:
  8. Buchholz U, Bernard H, Werber D, Böhmer MM, Remschmidt C, Wilking H, et al. German outbreak of Escherichia coli O104:H4 associated with sprouts. N Engl J Med. 2011;365(19):1763-70.
  9. European Food Safety Authority (EFSA). Tracing seeds, in particular fenugreek (Trigonella foenum-graecum) seeds, in relation to the Shiga toxin-producing E. coli (STEC) O104:H4 2011 Outbreaks in Germany and France. Parma: EFSA; 5 Jul 2011. Available from:
  10. Robert Koch Institute (RKI). Final presentation and evaluation of epidemiological findings in the EHEC O104:H4 outbreak, Germany 2011. Berlin: RKI; Sep 2011. Available from:,templateId=raw,property=publicationFile.pdf/EHEC_final_report.pdf
  11. European Centre for Disease Prevention and Control (ECDC) / European Food Safety Authority (EFSA). Shiga toxin/verotoxin-producing Escherichia coli in humans, food and animals in the EU/EEA, with special reference to the German outbreak strain STEC O104. Stockholm: ECDC; Jun 2011. Available from:

Back to Table of Contents
Previous Download (pdf)

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.